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Methods We studied 2573 men and women aged 
50–75 years. Among others, anthropometry was measured 
by standard protocol and dietary habits were investigated 
by food frequency questionnaire (EPIC). The intake of 
polyphenols was evaluated using US Department of Agri-
culture and Phenol-Explorer databases.
Results The mean total polyphenol intake was 
683.3 ± 5.8 mg/day. Non-alcoholic beverages represented 
the main food source of dietary polyphenols and pro-
vided 35.5% of total polyphenol intake, followed by fruits 
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Purpose Proper evaluation of polyphenols intake at the 
population level is a necessary step in order to establish 
possible associations with health outcomes. Available data 
are limited, and so far no study has been performed in peo-
ple with diabetes. The aim of this work was to document 
the intake of polyphenols and their major food sources in 
a cohort of people with type 2 diabetes and in socio-demo-
graphic subgroups.
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(23.0%), alcoholic beverages (14.0%), vegetables (12.4%), 
cereal products and tubers (4.6%), legumes (3.7%) and oils 
(2.1%); chocolate, cakes and nuts are negligible sources of 
polyphenols in this cohort. The two most important poly-
phenol classes contributing to the total intake were flavo-
noids (47.5%) and phenolic acids (47.4%). Polyphenol 
intake increased with age and education level and decreased 
with BMI; furthermore, in the northern regions of Italy, the 
polyphenol intake was slightly, but significantly higher than 
in the central or southern regions.
Conclusions The study documents for the first time the 
intake of polyphenols and their main food sources in peo-
ple with diabetes using validated and complete databases of 
the polyphenol content of food. Compared with published 
data, collected in people without diabetes, these results 
suggest a lower intake and a different pattern of intake in 
people with diabetes.
Keywords Polyphenols · Flavonoids · Phenolic acids · 
Diabetes · Food groups · Diet · Age · BMI · Geographical 
area · Intake · TOSCA.IT study
Introduction
Polyphenols are non-energetic, non-nutrient, bioactive 
compounds which cannot be synthesized by humans and 
are integral part of the human diet. These compounds are 
widely distributed in plant-based foods, such as fruit, veg-
etables, wholegrain cereals, cocoa and beverages, such as 
tea, coffee, wine [1].
 Dietary polyphenols constitute a heterogeneous group 
of compounds with more than 500 molecules with highly 
different structure, from simple molecules, such as phe-
nolic acids, to large ones, such as proanthocyanidin poly-
mers [1]. According to their chemical structure, they are 
classified into five major classes flavonoids, phenolic acids, 
lignans, stilbenes and a miscellaneous of minor polyphe-
nols that include among others tyrosol, alkylphenols and 
alkylmethoxyphenols and which will be described in this 
manuscript as “other polyphenols” [2]. Each class may be 
further divided into subclasses [2]. Flavonoids, lignans and 
stilbenes are usually found in foods as glycosides, whereas 
phenolic acids are most often present as esters with vari-
ous polyols; some other polyphenols, such as flavanols, are 
mainly present as free forms (aglycones) [1]. The chemical 
structure greatly influences the polyphenols absorption and 
bioavailability and possibly their health effects [3].
Over the last few years, there has been much interest in 
dietary polyphenols due to the recognition of their antioxi-
dant and anti-inflammatory properties and other beneficial 
effects upon human health [4–9]. Most of the evidence 
on the health effects of polyphenols comes from studies 
in vitro or in animals. Data in humans derive mainly from 
small trials, often involving non-physiological supplemen-
tation of polyphenols [10–13].
The evidence linking the physiological level of polyphe-
nol intake achieved with habitual diets and health is largely 
limited to flavonoids; furthermore, no data are available to 
date in people with diabetes [5–9].
Dietary treatment is part of the management of diabetes 
mellitus [14]. It is not known whether the dietary restric-
tion recommended to control hyperglycemia may impact 
on the intake of bioactive compounds such as polyphenols. 
Diabetes is a pro-inflammatory and pro-oxidant status, and 
the anti-inflammatory and antioxidant properties of dietary 
polyphenols may be particularly relevant in this high-risk 
group [15]. In addition, there is evidence that polyphenol 
supplements may improve glycated hemoglobin in peo-
ple with diabetes, although the antidiabetic effect of poly-
phenol intake in amounts achievable trough habitual diets 
remains controversial [15, 16].
In most prior studies, the polyphenol intake was cal-
culated using the US Department of Agriculture (USDA) 
databases [17, 18] which only contains data on flavonoids 
and does not allow to estimate the wide diversity of poly-
phenols in foods. The more recently published Phenol-
Explorer database [19, 20] gathers food composition data 
on all known polyphenols, either aglycones, glycosides or 
esters depending on how they are found in foods. A new 
module of the Phenol-Explorer database contains data on 
the effects of cooking and food processing on polyphenol 
contents, thus permitting to account for these effects and 
improve the reliability of the estimated polyphenol intake.
Proper evaluation of polyphenols intake is a necessary 
step in order to compare different populations and to estab-
lish possible associations with health outcomes. The aim 
of this work is to document the intake of polyphenols and 
their major food sources in a cohort of people with type 
2 diabetes and in socio-demographic subgroups using the 
most complete databases currently available. To our knowl-
edge, this is the first study providing intake estimation for a 
wide range of dietary polyphenols in people with diabetes.
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Methods
Study population
This is an observational study within the TOSCA.IT trial 
(NCT00700856), a study designed to evaluate the cardio-
vascular effects of two different hypoglycemic drug regi-
mens. Details on the study protocol, inclusion and exclu-
sion criteria have been published [21]. Briefly, 2573 people 
with type 2 diabetes, aged 50–75, were recruited in 60 cent-
ers distributed all over Italy. Patients with co-morbidities 
requiring a special dietary treatment were excluded from 
the analysis. For the purposes of this study, data collected 
at baseline, prior to randomization, are used. By protocol, 
all study participants were treated with metformin only. 
Among others, anthropometric measurements were taken 
according to a standard protocol. The Ethics Review Com-
mittee of the Coordinating Center and of each participating 
center have approved the study protocol. Written informed 
consent was obtained from all participants before entering 
the study.
Dietary assessment
The dietary habits were assessed with the Italian version 
of the European Prospective Investigation into Cancer and 
Nutrition (EPIC) questionnaire, a well-validated method 
for the assessment of eating habits in large epidemiologi-
cal studies [22, 23]. Details have been given elsewhere 
[24]. Briefly, the questionnaire contains 248 items includ-
ing the type of fat used as condiment, or added after cook-
ing. The respondent indicates the absolute frequency of 
consumption of each item (per day, week, month or year). 
The quantity of the food consumed was assessed from 
the respondent’s selection of pictures showing a small, 
medium and large portion size, with additional quanti-
fiers (e.g., “smaller than the small portion” or “between 
the small and medium portion”). Incomplete question-
naires and questionnaires with implausible data (i.e., 
energy intake less than 800 or greater than 5000 kcal/day) 
were excluded from the analyses. The mean time interval 
between completion of the baseline measurements and 
the FFQ ranged from the same day to one month later. A 
computer program, Nutrition Analysis of FFQ developed 
by the Epidemiology and Prevention Unit, Fondazione 
IRCCS, Istituto Nazionale dei Tumori, Milan, was used to 
convert questionnaire dietary data into frequencies of con-
sumption and average daily amounts of foods (g/day) and 
energy intake (Kcal/day). Nutrition analysis of FFQ was 
linked to the Italian Food Composition Tables (FCTs) for 
nutrients and energy assessment [25].
Estimation of polyphenol intake
The polyphenols composition of the diet was assessed 
using the USDA database for the calculation of flavonoids 
[17, 18] and the Phenol-Explorer database for the calcula-
tion of the polyphenols not contained in the USDA data-
base [19, 20] to enable examination of the polyphenol 
content of as many foods as possible. The effect of food 
cooking and processing was accounted for by applying 
polyphenol-specific retention factors. Missing data from 
cereal products, such as pizza, polenta, biscuits, crisp 
toasts, crackers and breadsticks, were estimated based on 
refined wheat flour data from the Phenol-Explorer data-
base. For processed foods, such as canned foods and pre-
packaged meals, the estimation was made according to the 
percentages of ingredients in the food products. Complex 
foods, such as cakes and sauces, were calculated as recipes 
taking into account the individual ingredients and their cor-
responding proportions as estimated from data available on 
the Internet. The polyphenol content of wholegrain cereals 
could not be calculated since information on the consump-
tion of these foods was not included in the questionnaire.
Information on type of coffee, espresso or decaffein-
ated, was reported in the food frequency questionnaire. The 
polyphenol content of espresso coffee was calculated as the 
mean between Arabica and Robusta, the brands more com-
mon in Italy, and multiplied by 2 to avoid underestimation 
of polyphenol from coffee espresso, as suggested by Parras 
[26]. For decaffeinated coffee, the polyphenol content of 
decaffeinated filtered coffee was considered. The polyphe-
nol composition of tea was obtained by a mix of herbal tea 
considering the unspecified type of herbal tea in the food 
frequency questionnaire. Individual polyphenol intake was 
calculated by multiplying the content of individual polyphe-
nols in each food by the daily consumption of each food.
The Phenol-Explorer® database contains data on the 
four main polyphenol classes: flavonoids, phenolic acids, 
stilbenes, lignans and also on a miscellaneous of minor 
polyphenols that include among others tyrosol, alkylphe-
nols and alkilmethossiphenols and which are described 
in the Phenol-Explorer database and in this manuscript as 
“other polyphenols”.
Statistical analysis
Data are presented as means and standard errors or fre-
quencies and percentages, as appropriate. The intake of 
total polyphenols and of the polyphenol classes is reported 
as absolute intake (mg/day) and as mg of polyphenols per 
1000 kcal, to correct for total energy intake. The contribu-
tion of each polyphenol class, and subclasses, to the total 
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polyphenol intake was also calculated as percentage of the 
total polyphenol intake.
The general linear model was used to analyze the intake 
of total polyphenols and polyphenol classes by sex, age, 
BMI, geographical area and lifestyle-related habits (smok-
ing and alcohol use). Adjustment for sex, age and BMI was 
performed except when these variables were part of the 
model. A P value <0.05 (two-tailed) was considered signifi-
cant. All analyses were conducted with the SPSS Statistics 
software (version 20.0; SPSS Inc.).
Results
The characteristics of the study cohort are described in 
Table 1 along with the energy intake and the composition of 
the diet. Mean age and BMI were 62.2 years and 30.3 kg/
m2. Average energy content of the diet was 1910 ± 14 kcal/
day. A total of 443 individual polyphenols were consumed 
by the study population, but only 124 were consumed in a 
mean quantity of at least 1 mg/day. Fifty-nine polyphenols 
documented in the food composition tables were either not 
consumed or their intake could not be calculated since their 
food sources are not part of the habitual diet in Italy, and 
therefore they were not included in the FFQ. We have not 
observed an association between the amount and the vari-
ety of intake of different classes of polyphenols.
The total polyphenol intake was 683.3 ± 5.8 mg/
day of which 324.7 ± 4.1 mg/day were flavo-
noids, 324.2 ± 3.0 mg/day were phenolic acids and 
34.6 ± 0.1 mg/day belonged to other polyphenols 
groups—i.e., stilbenes, lignans and “other polyphenols” 
(Table 2). Non-alcoholic beverages represented the 
main food group source of dietary polyphenols and pro-
vided 270.1 ± 3.8 mg/day of polyphenols (correspond-
ing to 39.5% of the total polyphenol intake), followed by 
fruits (156.9 ± 2.1 mg/day, 23.0%), alcoholic beverages 
(95.3 ± 3.0 mg/day, 14.0%), vegetables (84.6 ± 1.2 mg/
day, 12.4%), cereal products and tubers (31.5 ± 0.4 mg/
day, 4.6%), legumes (25.0 ± 0.5 mg/day, 3.7%) and oils 
(14.5 ± 0.15 mg/day, 2.1%); chocolate, cakes and nuts are 
negligible sources of dietary polyphenols in this population 
(Table 2).
As for polyphenol classes, the most important contribu-
tor to the intake of flavonoids was fruit (mainly apple), fol-
lowed by red wine, non-alcoholic beverages (mainly tea) 
and vegetables (mainly artichokes, spinach, onions and 
eggplant). Coffee was the most prominent source of phe-
nolic acids, followed by fruits and vegetables. Stilbenes 
were provided almost exclusively by red wine, and lignans 
by fruits. The miscellaneous of “other polyphenols” comes 
mainly from olive oil, followed by cereals and red wine 
(Table 2).
Regarding polyphenol subclasses, the two most impor-
tant contributors of total polyphenol intake were hydroxy-
cinnamic acids (44.6%) and flavanols (17.9%). Other rel-
evant contributors were flavonols (10.9%), anthocyanins 
(9.1%) and flavanones (5.2%). Flavones, tyrosol, hydroxy-
benzoic acids and alkylphenols accounted from 1.1 to 2.9% 
of total dietary polyphenols. Other subclasses contributed 
less than 1% each (Table 3).
The mean intake of the 20 most consumed individual 
polyphenols is given in Fig. 1. The four most consumed 
polyphenols were 5-caffeoylquinic acid (65.2 ± 5.3 mg/
day), 4-caffeoylquinic acid (49.7 ± 6.5 mg/day), 
3-caffeoylquinic acid (38.2 ± 5.1 mg/day) and (-)epigal-
locatechin 3-O-gallate (31.1 ± 8.6 mg/day) which were 
consumed in quantities above 30 mg/day. Their main food 
sources were coffee and tea. Additional six compounds, 
including (-)epicatechin, quercetin 3-O-glucoside, querce-
tin 3,4′-O-diglucoside, delphinidin, hesperetin and nar-
ingenin, were consumed in quantities ranging from 25 to 
11 mg/day; their main food sources were fruits (mainly 
apples, oranges, plums) and vegetables (mainly eggplant, 
onions). Other compounds were consumed in quantities 
below 10 mg/day (Fig. 1).
In Table 4, the energy-adjusted polyphenol intake and 
the main polyphenol classes are shown according to sex, 
age, BMI, socio-demographic and lifestyle-related hab-
its. The total polyphenol intake was similar for men and 
women with some differences in the pattern of intake. In 
particular, the intake of stilbenes and other polyphenols 
was significantly higher in men than in women, whereas 
for lignans the opposite was observed; the intake of flavo-
noids and phenolic acids was not different (Table 4). The 
Table 1  General characteristics of the study population and nutrient 
composition of the diet
TE total energy
M ± SE Median Minimum Maximum
Age (years) 62.2 ± 0.1 62.0 50 75
Diabetes duration 
(years)
8.5 ± 0.1 7.0 2 22
BMI (Kg/m2) 30.3 ± 0.1 29.8 20 45
Energy (Kcal/day) 1910 ± 14 1783 802 4883
Proteins (% of TE) 18.2 ± 2.5 17.7 10.5 25.1
Total fat (% of TE) 36.6 ± 6.0 34.3 20.1 41.4
SFA (% of TE) 12.2 ± 2.5 13.8 4.4 17.6
Carbohydrates  
(% of TE)
45.1 ± 7.2 50.1 35.6 64.0
Added sugars  
(% of TE)
2.4 ± 3.2 3.8 0.0 10.1
Fiber (g/1000 kcal/
day)
10.7 ± 2.7 11.9 7.0 21.3
Alcohol (g/day) 11.1 ± 0.3 3.5 0.0 166.6
Eur J Nutr 
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intake of total polyphenols increased with age, mainly due 
to flavonoids and stilbenes, whereas no significant relation 
with age was found for phenolic acids, lignans and other 
polyphenols. BMI was inversely associated with the intake 
of total polyphenols and all polyphenol classes, except 
for lignans. A significant impact of geographical area was 
also observed; people living in the northern regions had a 
slightly, but significantly higher total polyphenols intake 
than people living in the central or southern regions. In par-
ticular, the intake of flavonoids and stilbenes was higher 
in the northern regions, due to higher wine consumption, 
whereas the opposite was found for phenolic acids and lig-
nans, due to a higher consumption of cereals and legumes 
in the southern regions. Other significant correlates of poly-
phenol intake were education level and smoking status. 
Educational level was directly associated with polyphenol 
intake, particularly phenolic acids. Current smoking was 
associated with higher polyphenol intake—mainly phenolic 
acids derived from coffee consumption—than former or 
never smoking. As expected, alcohol drinking was associ-
ated with significantly higher polyphenol intake, mainly fla-
vonoids and stilbenes derived from red wine consumption.
Discussion
The study provides a detailed description of a wide range 
of polyphenol intake and their major food group and indi-
vidual food sources in people with type 2 diabetes. To esti-
mate the daily polyphenol intake is an essential step toward 
Table 2  Intake (mg/day) of total polyphenols and polyphenol classes according to food group sources
M ± SE
a  The first 4 main food sources in each food group are given; a lower number of foods indicate the absence of other food sources that contained
Polyphenols in the food group considered
b The term “soup” indicates a primarily liquid food, generally served warm, that is made by combining different legumes with a vegetable broth
Food group Total polyphe-
nols (mg/day)
Flavonoids 
(mg/day)
Phenolic acids 
(mg/day)
Stilbenes 
(mg/day)
Lignans  
(mg/day)
Other polyphe-
nols (mg/day)
Main food 
sources (% 
contribution to 
total polyphenol 
intake in the food 
group)a
Non-alcoholic 
beverages
270.1 ± 3.8 57.1 ± 2.6 211.7 ± 2.8 – – 1.7 ± 0.05 Coffee (54), tea 
(27), decaffein-
ated coffee (9), 
orange juice (7)
Fruits 156.9 ± 2.1 104.5 ± 1.4 48.9 ± 0.7 0.03 ± 0.01 3.5 ± 0.06 0.02 ± 0.01 Apple (37), 
orange (13), 
plum (10), 
peach (8)
Alcoholic  
beverages
95.3 ± 3.0 74.0 ± 2.4 14.4 ± 0.4 3.4 ± 0.1 – 3.5 ± 0.1 Red wine (93), 
wine (4), beer 
(1)
Vegetables 84.6 ± 1.2 49.1 ± 0.8 35.2 ± 0.6 – 0.26 ± 0.02 – Artichokes (40), 
spinach (20), 
onions (18), 
eggplant (9)
Cereal products & 
tubers
31.5 ± 0.4 12.6 ± 0.2 11.2 ± 0.2 – 0.05 ± 0.01 7.7 ± 0.2 Refined-grain 
wheat flour 
(61), potatoes 
(19), wholegrain 
wheat flour 
(11), pasta (9)
Legumes 25.0 ± 0.5 24.2 ± 0.5 0.8 ± 0.1 0.02 ± 0.00 – – Soupb (59), beans 
(39)
Fat and oils 14.5 ± 0.15 0.05 ± 0.001 0.07 ± 0.001 – 0.26 ± 0.003 14.1 ± 0.15 Olive oil (99)
Cakes and choco-
late
3.6 ± 0.2 3.0 ± 0.2 0.59 ± 0.03 <0.01 – – Chocolate (92), 
jam (7)
Nuts 0.52 ± 0.03 0.15 ± 0.01 0.38 ± 0.02 <0.001 <0.001 – –
Total foods 683.3 ± 5.8 324.7 ± 4.1 324.2 ± 3.0 3.5 ± 0.11 4.1 ± 0.06 27.0 ± 0.27
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the understanding of the beneficial effects of dietary poly-
phenols upon human health. To our knowledge, this is the 
first study which documents the polyphenols content of the 
diet in people with diabetes. The comparison with prior 
studies is therefore limited to data collected in the general 
population. In particular, two recent studies in cohorts of 
people without diabetes have used a methodology similar 
to ours [27–29]. One is the European Prospective Inves-
tigation into Cancer and Nutrition (EPIC) study that has 
evaluated the dietary polyphenol intake in several European 
cohorts [27, 28]; the other is the PREDIMED study that has 
evaluated the intake of polyphenols in a group of Spanish 
people at high CVD risk [29]. The average total polyphe-
nol intake in our study is lower than in the EPIC cohorts 
[27, 28], including the Italian cohorts (one in Varese, one 
in Turin, one in Florence, one in Naples and one in Ragusa) 
and is also lower than reported in PREDIMED [29]. The 
differences can be partly explained by a lower consumption 
of coffee and alcoholic beverages in our study population, 
as compared to the other two studies. In addition, dietary 
treatment is part of the management of diabetes and accord-
ing to the current nutritional recommendations [14], some 
food items which elicit a high glucose response but are also 
good sources of polyphenols (fruit and chocolate products) 
are restricted in people with diabetes. Although compliance 
with the dietary recommendations was not assessed at the 
individual level in this study, prior analyses on this same 
dataset indicate that on the overall adherence to the nutri-
tional recommendations is fair [30] and may contribute to 
limit polyphenol intake. There is evidence for an inverse 
relationship between polyphenol intake and risk of diabetes 
Table 3  Contribution (%) of classes and subclasses of polyphenols 
to total intake
Polyphenol classes and subclasses Contribution (%)
Total polyphenols 100
Flavonoids 47.5
 Flavanols 17.9
 Flavonols 10.9
 Anthocyanins 9.1
 Flavanones 5.21
 Flavones 2.92
 Chalcones 0.91
 Dihydroflavonols 0.63
 Dihydrochalcones 0.07
 Isoflavonoids 0.02
Phenolic acids 47.4
 Hydroxycinnamic acids 44.6
 Hydroxybenzoic acids 1.94
 Hydroxyphenylacetic acids 0.03
Stilbenes 0.8
Lignans 0.5
Other polyphenols 3.8
 Tyrosols 2.4
 Alkylphenols 1.1
 Other polyphenols family 0.22
 Hydroxybenzaldehydes 0.09
 Alkylmethoxyphenols 0.03
 Hydroxycoumarins 0.02
 Furanocoumarins 0.01
 Methoxyphenols 0.003
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Fig. 1  Intake (mg/day) of the top 20 most consumed individual polyphenols
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[7]; therefore, due the cross sectional study design, we can-
not exclude that a low polyphenol intake may antedate the 
development of diabetes, rather than being a consequence 
of the dietary treatment.
Interestingly, a similar number of individual polyphenols 
(nearly 100) were consumed in average quantities higher 
than 1 mg/day in our study, and in the EPIC and PRED-
IMED studies, but there are considerable differences in the 
pattern of polyphenol intake which, unlike other studies, in 
our population is characterized by an equal contribution of 
flavonoids and phenolic acids (i.e., 47.5 and 47.4%, respec-
tively). Since the health effects of polyphenols depend on 
the amount consumed, and on their bioavailability, which 
in turn depends on the chemical structure, the lower intake 
and the differential pattern of dietary polyphenols in people 
with diabetes, as compared to non-diabetic cohorts, may be 
relevant.
Age, anthropometric and socio-demographic variables 
significantly influence the amount and the pattern of poly-
phenols intake. Men had a higher intake of stilbenes and 
“other polyphenols” than women, as men tend to drink 
more wine, particularly red wine. The intake of flavonoid 
and stilbenes increased with age; the observed differences 
were largely due to the differential consumption of wine 
and tea. To the contrary, BMI was inversely associated with 
polyphenol intake; participants in the lower tertiles of BMI 
had a significantly higher consumption of flavonoid, phe-
nolic acids, stilbenes and “other polyphenols”. A signifi-
cant impact of geographical area was also observed; peo-
ple living in the northern regions had a significantly higher 
intake of flavonoids and stilbenes, whereas the opposite 
was found for phenolic acids and lignans; the observed 
differences were largely due to variations in wine, tea and 
coffee consumption. In addition, a higher educational level 
and the current smoking status were associated with sig-
nificantly higher phenolic acids, mainly due to coffee con-
sumption. A differential intake of polyphenols in relation to 
age, BMI, education and geographical area is also reported 
in the EPIC study [27, 28], conferring external consistency 
to our findings.
The major strengths of this study are the large popula-
tion-based cohort—which makes results generalizable to 
people with diabetes in Italy—and the use of a standardized 
FFQ. The use of comprehensive databases for the estima-
tion of the polyphenol content of the diet confers further 
relevance to the findings. The major limitation is the lack of 
a control group of non-diabetic people which only allows 
comparison with data in the literature. Second, the dietary 
information was retrieved only once and thus may be prone 
to recall bias and seasonal variation. Finally, the lack of 
information on the consumption of wholegrain cereals does 
not allow the estimation of polyphenol content in this food 
source.
However, the consumption of wholegrain cereals is very 
low in the Italian population of this age range, as reported 
by the INRAN-SCAI survey [31] (Istituto Nazionale di 
Ricerca per gli Alimenti e la Nutrizione–Studio sui Con-
sumi Alimentari in Italia); therefore, we are confident that 
they are a negligible source of polyphenols in our study.
In summary, this study documents polyphenol intake 
in people with diabetes and gives an exhaustive descrip-
tion of the pattern of intake and of the main food sources 
of polyphenols in a cohort of people with type 2 diabetes. 
The comparison with published data collected with the 
same methods in people without diabetes [27–29] suggest 
that people with diabetes have a lower intake of total poly-
phenols and a differential pattern of intake. As the health 
effects of polyphenols depend on the amount consumed 
and on their bioavailability—which varies greatly between 
different compounds—these data may serve as a valuable 
tool to establish the future associations between the amount 
and type of dietary polyphenols and the risk of chronic dis-
eases (namely CVD and cancer) in a population at high risk 
such as people with diabetes.
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Appendix: TOSCA.IT Study Group (in order 
of number of patients contributed)
Napoli—Università “Federico II”: Angela Albarosa Riv-
ellese, Sara Cocozza, Stefania Auciello, Anna Amelia 
Turco; Verona—Ospedale Civile di Verona: Enzo Bonora, 
Massimo Cigolini, Isabella Pichiri, Corinna Brangani, 
Elena Tomasetto; Perugia—Università di Perugia: Gabri-
ele Perriello, Alessia Timi; Catania—Ospedale Garibaldi-
Nesima: Sebastiano Squatrito, Tiziana Sinagra, Sara Long-
hitano, Vanessa Tropea; Rimini—Ospedale Infermi di 
Rimini: Giorgio Ballardini, Anna Carla Babini, Raffaella 
Ripani; Massa Carrara—ASL 1 Massa Carrara SSD Dia-
betologia: Giovanna Gregori, Maria Dolci, Laura Bruselli, 
Isabella Salutini, Mary Mori, Fabio Baccetti; Padova—
Complesso Socio-Sanitario ai Colli: Annunziata Lapolla, 
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Giovanni Sartore, Silvia Burlina, Nino Cristiano Chilelli; 
Latina—Ospedale S. Maria Goretti di Latina: Raffaella 
Buzzetti, Chiara Venditti, Stella Potenziani, Angela Car-
lone; Palermo—Università degli Studi di Palermo: Aldo 
Galluzzo†, Carla Giordano, Vittoria Torregrossa; Chiavari 
(GE)—ASL Chiavarese: Laura Corsi, Giacomo Cuneo, 
Simona Corsi; Eboli (SA)—Distretto 64: Biagio Tizio, 
Gennaro Clemente; Potenza—Rete ASP—Potenza—
Villa d’Agri—Lagonegro: Giuseppe Citro, Maria Natale, 
Vita Salvatore; Livorno—ASL 6 Livorno: Graziano Di 
Cianni, Emilia Lacaria, Laura Russo; L’Aquila—Ospedale 
San Salvatore: Rossella Iannarelli, Antonella De Grego-
rio, Filomena Sciarretta, Settimio D’Andrea; Atri (TE)—
Ospedale di Atri: Valeria Montani, Emanuela Cannarsa, 
Katia Dolcetti; Genova—DIMI—Università di Genova: 
Renzo Cordera, Laura Affinito Bonabello, Chiara Maz-
zucchelli; Chieri (TO)—ASL Torino 5: Carlo Bruno 
Giorda, Francesco Romeo, Caterina Bonetto; Lanciano 
(CH)—Presidio Ospedaliero di Lanciano: Daniela Ante-
nucci, Maria Pompea Antonia Baldassarre, Livia Santa-
relli; Napoli—Azienda Ospedaliera Universitaria “Poli-
clinico”: Ciro Iovine, Rossella Nappo, Ornella Ciano; 
Parma—AOU di Parma: Elisabetta Dall’Aglio, Giovanni 
Mancastroppa; Udine—SOC di Endocrinologia e Malat-
tie del Metabolismo: Franco Grimaldi, Laura Tonutti; 
Ancona—INRCA—IRCCS: Massimo Boemi, Federica 
D’Angelo; Roma—Ospedale Pertini: Sergio Leotta, Lucia 
Fontana; Roma—Policlinico di Tor Vergata: Davide Lauro, 
Maria Elena Rinaldi; Foggia—OORR di Foggia: Mauro 
Cignarelli, Olga La Macchia, Stefania Fariello; Ferrara—
Arcispedale “S. Anna”: Franco Tomasi, Chiara Zamboni, 
Nicoletta Dozio; Bergamo—Azienda Ospedaliera Papa 
Giovanni XXIII: Roberto Trevisan, Cristiana Scaranna; 
Pisa—Ospedale di Cisanello: Stefano Del Prato, Rob-
erto Miccoli, Cristina Bianchi, Monia Garofolo; Roma—
Azienda Ospedaliera S. Andrea: Giuseppe Pugliese, Laura 
Salvi, Graziela Rangel, Martina Vitale; Pistoia—UO 
di Diabetologia USL 3 Pistoia: Roberto Anichini, Anna 
Tedeschi, Elisa Corsini; Messina—Policlinico G. Mar-
tino: Domenico Cucinotta, Antonino Di Benedetto, Loretta 
Giunta, Maria Concetta Ruffo; Treviglio—Ospedale di 
Treviglio: Antonio Carlo Bossi, Rita Carpinteri; Siena—
Policlinico “Le Scotte”: Francesco Dotta, Elena Cec-
carelli; Ravenna—Ospedale Santa Maria Delle Croci: 
Paolo Di Bartolo, Chiara Caselli, Alessandra Luberto; 
Cesena—Ospedale M. Bufalini: Costanza Santini, Ari-
anna Mazzotti, Giovanni Calbucci; Pescara—Ospedale 
Civile di Pescara: Agostino Consoli, Federica Ginestra; 
Prato—Ospedale di Prato: Maria Calabrese, Alessia 
Zogheri; Arezzo—Ospedale San Donato: Lucia Ricci; 
Bari—Policlinico Consorziale: Francesco Giorgino, Luigi 
Laviola, Claudia Ippolito, Lucia Tarantino; Padova—
Policlinico di Padova: Angelo Avogaro, Monica Vedovato; 
Catanzaro—”Università Magna Graecia”: Agostino 
Gnasso, Claudio Carallo, Caterina Scicchitano; Piacenza—
Ospedale Guglielmo da Saliceto: Donatella Zavaroni, Ste-
fania Livraga; Torino—Ospedale Molinette di Torino: 
Paolo Cavallo Perin, Paolo Fornengo, Tania Prinzis; San 
Giovanni Rotondo—Ospedale Casa Sollievo della Soffer-
enza: Salvatore De Cosmo, Antonio Pio Palena, Simonetta 
Bacci; Firenze—Ospedale Careggi—Pontenuovo: Edoardo 
Mannucci, Caterina Lamanna; Messina—Ospedali Riuniti 
Papardo—Piemonte di Messina: Pietro Pata, Gabriele Let-
tina; Campobasso—Presidio Ospedaliero A.S.RE. Molise: 
Antimo Aiello, Angelina Barrea; Spoleto—Ospedale San 
Matteo degli Infermi: Carlo Lalli, Maura Scarponi; Gal-
larate (VA)—Azienda Ospedaliera “ S. Antonio Abate” 
di Gallarate: Ivano Franzetti, Raffaella Radin; Lecce—
Poliambulatorio Cittadella della Salute: Rosalia Serra, 
Francesca Petrachi; Cosenza—Azienda Sanitaria Provin-
ciale (Distretti di Castrovillari, Diamante e Scalea): Vin-
cenzo Asprino; Verona—Ospedale Civile “G. Fracastoro” 
di San Bonifacio: Claudio Capra, Massimo Cigolini; Ter-
racina (LT)—Polo Sud ASL di Latina: Elisa Forte, Stella 
Potenziani; Bologna—Policlinico S. Orsola Malpighi: 
Giulio Marchesini Reggiani, Gabriele Forlani, Luca Mon-
tesi, Natalia Mazzella; Milano—Istituto Scientifico San 
Raffaele: Pier Marco Piatti, Lucilla Monti, Michela Stuc-
cillo; Napoli—ASL NA2—in cooperazione con Università 
“Federico II” di Napoli: Pasquale Auletta, Ettore Petraroli, 
Giuseppe Capobianco; Napoli—ASL NA3—in cooper-
azione con Università “Federico II” di Napoli: Geremia 
Romano, Michele Cutolo, Giosetta De Simone, Gennaro 
Caiazzo, Peppe Nunziata, Susy Sorrentino; Salerno—ASL 
di Salerno in cooperazione con Università di Napoli “Fed-
erico II”: Umberto Amelia, Pasqualino Calatola, Gelsomina 
Capuano.
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